Frequency of CD4+CD25+Foxp3+ cells in peripheral blood in relation to urinary bladder cancer malignancy indicators before and after surgical removal.
about
Tumor-infiltrating immune cell subpopulations influence the oncologic outcome after intravesical Bacillus Calmette-Guérin therapy in bladder cancer.Repeated Long-Term DT Application in the DEREG Mouse Induces a Neutralizing Anti-DT Antibody Response.A Murine Orthotopic Bladder Tumor Model and Tumor Detection System.Decreased Helios Expression in Regulatory T Cells in Acute Coronary Syndrome.Systematic review and meta-analysis of the prognostic value of preoperative platelet-to-lymphocyte ratio in patients with urothelial carcinoma.mRNA Expression levels of genes involved in antitumor immunity: Identification of a 3-gene signature associated with prognosis of muscle-invasive bladder cancer.Elevated peripheral blood B lymphocytes and CD3+CD4-CD8- T lymphocytes in patients with non-small cell lung cancer: A preliminary study on peripheral immune profile.
P2860
Q37457728-C73004D9-E5EB-4021-868B-19FB19A26730Q37542566-7254553A-9DF7-45C0-BF85-449B2EC6CB71Q38719717-F488C0B7-B2F5-4CFD-8614-246586B5C11DQ47134151-88AE5674-7651-47C6-AC04-F0E5940494C1Q47135526-D7E16D06-58DA-4AC3-884A-44A834B30D95Q47393384-F23489B9-47F7-4465-8860-FDEC4E312BC5Q55362929-FC8BB975-1EBB-4E36-9229-5A71F59AD1A2
P2860
Frequency of CD4+CD25+Foxp3+ cells in peripheral blood in relation to urinary bladder cancer malignancy indicators before and after surgical removal.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Frequency of CD4+CD25+Foxp3+ c ...... re and after surgical removal.
@en
type
label
Frequency of CD4+CD25+Foxp3+ c ...... re and after surgical removal.
@en
prefLabel
Frequency of CD4+CD25+Foxp3+ c ...... re and after surgical removal.
@en
P2860
P356
P1433
P1476
Frequency of CD4+CD25+Foxp3+ c ...... re and after surgical removal.
@en
P2093
Jerzy Siekiera
Wojciech Jóźwicki
P2860
P304
11450-11462
P356
10.18632/ONCOTARGET.7199
P407
P577
2016-02-05T00:00:00Z